BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 3354549)

  • 1. Evaluation of methods for the prospective identification of early fetal losses in environmental epidemiology studies.
    Sweeney AM; Meyer MR; Aarons JH; Mills JL; LaPorte RE
    Am J Epidemiol; 1988 Apr; 127(4):843-50. PubMed ID: 3354549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and sensitive nonradioactive method for the detection of urinary human chorionic gonadotropin and diagnosis of early human pregnancy. I. Multiple-unit test.
    Banik UK; Givner ML
    Fertil Steril; 1979 Oct; 32(4):420-5. PubMed ID: 488429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neocept: a simple, sensitive urine test of early pregnancy in women undergoing ovulation induction.
    Wang CF; Gemzell C
    J Reprod Med; 1982 Apr; 27(4):193-5. PubMed ID: 6808132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verification of early pregnancy tests in a multicenter trial.
    Jovanovic L; Singh M; Saxena BB; Mills JL; Tulchinsky D; Holmes LB; Simpson JL; Metzger BE; Labarbera A; Aarons J
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):201-5. PubMed ID: 3809174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
    Marrs RP; Kletzky OA; Howard WF; Mishell DR
    Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norplant implants: the mechanism of contraceptive action.
    Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of 10 kits for determination of human choriogonadotropin in serum.
    Rasor JL; Farber S; Braunstein GD
    Clin Chem; 1983 Oct; 29(10):1828-31. PubMed ID: 6616833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation.
    Reis MF; Aniceto P; Aguiar P; Simão F; Segurado S
    Int J Hyg Environ Health; 2007 May; 210(3-4):419-27. PubMed ID: 17336148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A commercial pregnancy test modified for field studies of fetal loss.
    Holman DJ; Rasheed FN; Stroud CM; Brindle E; O'Connor KA; Campbell KL
    Clin Chim Acta; 1998 Mar; 271(1):25-44. PubMed ID: 9564555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB; Holmes J; Barker G
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural limits of pregnancy testing in relation to the expected menstrual period.
    Wilcox AJ; Baird DD; Dunson D; McChesney R; Weinberg CR
    JAMA; 2001 Oct; 286(14):1759-61. PubMed ID: 11594902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion and excretion of human chorionic gonadotropin during early pregnancy.
    Lohstroh PN; Overstreet JW; Stewart DR; Nakajima ST; Cragun JR; Boyers SP; Lasley BL
    Fertil Steril; 2005 Apr; 83(4):1000-11. PubMed ID: 15820813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five recent urinary tests for early pregnancy evaluated.
    Ryder KW; Munsick RA; Oei TO; Young PC; Blackford HF
    Clin Chem; 1983 Oct; 29(10):1812-4. PubMed ID: 6616829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine.
    Cole LA; Seifer DB; Kardana A; Braunstein GD
    Am J Obstet Gynecol; 1993 May; 168(5):1580-6. PubMed ID: 8498446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peri-implantation urinary hormone monitoring distinguishes between types of first-trimester spontaneous pregnancy loss.
    Foo L; Johnson S; Marriott L; Bourne T; Bennett P; Lees C
    Paediatr Perinat Epidemiol; 2020 Sep; 34(5):495-503. PubMed ID: 32056241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective assessment of early fetal loss using an immunoenzymometric screening assay for detection of urinary human chorionic gonadotropin.
    Taylor CA; Overstreet JW; Samuels SJ; Boyers SP; Canfield RE; O'Connor JF; Hanson FW; Lasley BL
    Fertil Steril; 1992 Jun; 57(6):1220-4. PubMed ID: 1601143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of radioimmunoassays using mono- and polyclonal antibodies for the quantitation of human chorionic gonadotropin in early pregnancy.
    Heip J; Liu Y; Devroey P; Naaktgeboren N; Van Steirteghem AC
    Ann Biol Clin (Paris); 1986; 44(2):131-8. PubMed ID: 3752628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical abortion in patients with recurrent fetal loss.
    Oka C; Makino T; Itakura I; Hara T; Nozawa S; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):239-40. PubMed ID: 1707432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The measurement of human chorionic gonadotropin for pregnancy testing.
    Feldkamp CS; Pfeffer WH
    Henry Ford Hosp Med J; 1982; 30(4):207-13. PubMed ID: 7169378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary hormone levels at the time of ovulation and implantation.
    Lasley BL; Stabenfeldt GH; Overstreet JW; Hanson FW; Czekala N; Munro C
    Fertil Steril; 1985 Jun; 43(6):861-7. PubMed ID: 3996630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.